In Ireland, Boston Scientific, a global medical device manufacturer, has announced plans for layoffs at its operations, which employ over 7,000 workers across Galway, Cork, and Tipperary. This decision was communicated to the Department of Enterprise, Tourism and Employment through a collective redundancy notification on July 22, 2026. The company is still hiring at its facilities, despite the impending job cuts. The layoffs come shortly after Boston Scientific revealed a $75 million expansion plan for its Galway facilities, which included the establishment of new laboratories. The restructuring plan, approved by Boston Scientific, is expected to lead to some headcount reductions globally. The company anticipates that the restructuring will cost between $700 million and $800 million, with a significant portion of the savings earmarked for reinvestment in strategic growth initiatives. The spokesperson for Boston Scientific emphasized the importance of Ireland in the company's global operations, highlighting the contributions of its Irish workforce over the past 30 years. Despite the layoffs, Boston Scientific's net sales grew by 7.5% year-on-year, reaching nearly $5.5 billion in the second quarter of 2026. This growth indicates that the company is still performing well financially, even as it undertakes a restructuring process that will affect its workforce. The decision to cut jobs, particularly after announcing an expansion, raises questions about the company's long-term strategy and operational efficiency. The situation reflects broader trends in the medical device industry, where companies are often faced with the need to balance growth and cost management. As Boston Scientific navigates these challenges, the impact on its employees and the local economy in Ireland will be closely monitored. The company remains committed to its operations in Ireland, but the uncertainty surrounding the layoffs may affect employee morale and public perception of the company’s commitment to its workforce.